Leucomentin-6
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Enzyme inhibitors |
Catalog number | BBF-02257 |
CAS | |
Molecular Weight | 750.74 |
Molecular Formula | C42H38O13 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Paxillus panuoides. It is a free radical scavenger. It has strong inhibitory effect of lipid peroxidation with IC50 of 0.06 μg/mL. The IC50 of reference Leucomentin-4 is 0.11 μg/mL.
- Specification
- Properties
- Reference Reading
- Price Product List
IUPAC Name | [2,5-bis(4-hydroxyphenyl)-3,4,6-tris[[(Z)-3-[(2R,3S)-3-methyloxiran-2-yl]prop-2-enoyl]oxy]phenyl] (2Z,4E)-hexa-2,4-dienoate |
Canonical SMILES | CC=CC=CC(=O)OC1=C(C(=C(C(=C1OC(=O)C=CC2C(O2)C)C3=CC=C(C=C3)O)OC(=O)C=CC4C(O4)C)OC(=O)C=CC5C(O5)C)C6=CC=C(C=C6)O |
InChI | InChI=1S/C42H38O13/c1-5-6-7-8-33(45)52-39-37(26-9-13-28(43)14-10-26)41(54-35(47)21-18-31-24(3)50-31)42(55-36(48)22-19-32-25(4)51-32)38(27-11-15-29(44)16-12-27)40(39)53-34(46)20-17-30-23(2)49-30/h5-25,30-32,43-44H,1-4H3/b6-5+,8-7-,20-17-,21-18-,22-19-/t23-,24-,25-,30+,31+,32+/m0/s1 |
InChI Key | MAWFHXHTJMBMNB-UFJMPPEBSA-N |
Appearance | Gray Powder |
Solubility | Soluble in Methanol |
BBF-01851 | Fumagillin | Inquiry |
BBF-03827 | Polymyxin B sulphate | Inquiry |
BBF-03427 | Tubercidin | Inquiry |
BBF-03862 | Cefozopran hydrochloride | Inquiry |
BBF-04301 | Tulathromycin A | Inquiry |
BBF-04609 | 1,1-Dimethylbiguanide hydrochloride | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
